EP0931091A4 - Inhibiteurs des pla 2 - Google Patents

Inhibiteurs des pla 2

Info

Publication number
EP0931091A4
EP0931091A4 EP97941734A EP97941734A EP0931091A4 EP 0931091 A4 EP0931091 A4 EP 0931091A4 EP 97941734 A EP97941734 A EP 97941734A EP 97941734 A EP97941734 A EP 97941734A EP 0931091 A4 EP0931091 A4 EP 0931091A4
Authority
EP
European Patent Office
Prior art keywords
pla
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97941734A
Other languages
German (de)
English (en)
Other versions
EP0931091A1 (fr
Inventor
Katherine Bryant
W Bret Church
Adam Inglis
Kieran Scott
Albert Tseng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO2661A external-priority patent/AUPO266196A0/en
Priority claimed from AUPO2660A external-priority patent/AUPO266096A0/en
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Publication of EP0931091A1 publication Critical patent/EP0931091A1/fr
Publication of EP0931091A4 publication Critical patent/EP0931091A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP97941734A 1996-09-27 1997-09-29 Inhibiteurs des pla 2 Withdrawn EP0931091A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPO266096 1996-09-27
AUPO2661A AUPO266196A0 (en) 1996-09-27 1996-09-27 PLA2 inhibitory D-peptides
AUPO2660A AUPO266096A0 (en) 1996-09-27 1996-09-27 Inhibitors of PLA2
AUPO266196 1996-09-27
PCT/AU1997/000648 WO1998013376A1 (fr) 1996-09-27 1997-09-29 Inhibiteurs des pla¿2?

Publications (2)

Publication Number Publication Date
EP0931091A1 EP0931091A1 (fr) 1999-07-28
EP0931091A4 true EP0931091A4 (fr) 2000-06-14

Family

ID=25645280

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97941734A Withdrawn EP0931091A4 (fr) 1996-09-27 1997-09-29 Inhibiteurs des pla 2

Country Status (4)

Country Link
EP (1) EP0931091A4 (fr)
JP (1) JP2001501199A (fr)
CA (1) CA2266746A1 (fr)
WO (1) WO1998013376A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP076797A0 (en) * 1997-12-05 1998-01-08 Active (Pla) R&D Pty Ltd Phospholipase inhibitor
FI20105629A0 (fi) * 2010-06-03 2010-06-03 Estaja Oy Menetelmä lipidiaktivoituvien entsyymien peptidi-inhibiittoreiden valmistamiseksi ja menetelmällä valmistettuja peptidejä
CN121941699A (zh) * 2023-09-04 2026-04-28 菲拉蒙有限公司 表皮生长因子受体抑制剂

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001215A1 (fr) * 1991-07-04 1993-01-21 Garvan Institute Of Medical Research Composes inhibant l'activite enzymatique des phospholipases a2 (pla2)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001215A1 (fr) * 1991-07-04 1993-01-21 Garvan Institute Of Medical Research Composes inhibant l'activite enzymatique des phospholipases a2 (pla2)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A TSENG ET AL.: "Native peptide inhibition", JOURNAL OF BIOLOGICAL CHEMISTRY., vol. 271, no. 39, 27 September 1996 (1996-09-27), AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD., US, pages 23992 - 23998, XP002135015, ISSN: 0021-9258 *
See also references of WO9813376A1 *

Also Published As

Publication number Publication date
CA2266746A1 (fr) 1998-04-02
EP0931091A1 (fr) 1999-07-28
JP2001501199A (ja) 2001-01-30
WO1998013376A1 (fr) 1998-04-02

Similar Documents

Publication Publication Date Title
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
FI963597L (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A0 (fi) Matriisimetalloproteaasi-inhibiittorit
IS4419A (is) Kryddstaukur fyrir krydd
ID24669A (id) Turunan-turunan dolastatin 15
ID18010A (id) Oligosakarida termodifikasi
NO996108D0 (no) 9-oksinerytromycinderivater
FI971784L (fi) Apolipoproteiini B-synteesin estäjiä
ID18417A (id) Inhibitor ditentat metaloprotease
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
DE69736109D1 (de) Differenzierungsinhibitor
NO992059D0 (no) 2-metoksyfenylpiperazinderivater
FI962420A0 (fi) Foerstaerkare med laogbrus
FI962777A0 (fi) Meesan sy¦tt¦järjestelmä
FI962271A0 (fi) Hakkurivirtalähdejärjestely
DE69720957T2 (de) Ace-hemmer
EP1007548A4 (fr) Inhibiteur de thrombine provenant de la mouche tse-tse
ATA185196A (de) Ionisator
FI960432A0 (fi) Myyntiteline
FI962781A0 (fi) Ikkuna
KR970062986U (ko) 볼트
SE9601982D0 (sv) Tifaret 6
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990422

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000427

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020326

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020806